Market Report
Evraz considering demerger of its coal assets
Evraz said on Tuesday that it is considering a potential demerger of its coal assets.
Moderna on track to deliver 100m doses of Covid-19 vaccine by end of Q1
Moderna said on Tuesday that 30. 4m doses of its Covid-19 vaccine have been supplied to date to the US government and it is on track to deliver around 100m doses by the end of the first quarter.
Etsy surges after Elon Musk tweets that he's a fan
Etsy shares rallied on Tuesday after Tesla and SpaceX boss Elon Musk put out a positive tweet about the online marketplace.
Berenberg raises target price on Senior
Analysts at Berenberg hiked their target price on aerospace and defence outfit Senior from 50. 0p to 85. 0p on Tuesday but noted that although the group was "on steadier footing", its recovery path still remained "unclear".
Flowtech Fluidpower revenue falls in 'challenging' year
Flowtech Fluidpower updated the market on its trading in 2020 on Tuesday, reporting that in line with the “challenging” market conditions it had experienced as a result of the Covid-19 pandemic, it was expecting to report revenue of £95. 1m for the year.
Sweden’s EQT to buy US-based Exeter Property Group for $1.9bn
Swedish private equity firm EQT has agreed to buy US real estate investment manager Exeter Property Group for $1. 9bn in cash and shares.
US pre-open: Stocks tick higher ahead of earnings deluge
Wall Street futures were mixed prior to the open on Tuesday ahead of a busy day for corporate earnings.
Revenue and earnings rise at Eagle Eye
Marketing software-as-a-service provider Eagle Eye updated the market on its first half on Tuesday, reporting an 8% improvement in group revenue to £10. 8m.
FDA approves next two phases of Faron's Traumakine trial
Clinical-stage biopharmaceuticals company Faron Pharmaceuticals announced on Tuesday that the United States Food and Drug Administration (FDA) has approved the phase 2 and 3 ‘HIBISCUS’ trial assessing its intravenous IFN beta-1a ‘Traumakine’ for the treatment of hospitalised patients with Covid-19.
Europe midday: Shares rebound despite Covid fears, EU threat over vaccines
European shares rebounded strongly at midday as investors shrugged off concerns over tighter coronavirus travel restrictions and the slower pace of vaccine rollouts across the Continent.
Simplybiz revenues and margins remain 'resilient' in 2020
Fintech outfit Simplybiz said on Tuesday that both revenues and underlying margins had remained "resilient" in 2020 despite the ongoing Covid-19 pandemic.
London midday: Stocks extend gains as travel & leisure sectors recover
London stocks had extended gains by midday on Tuesday despite the release of uninspiring jobs and retail sales data, as travel and leisure issues recovered.
Europe open: Shares inch higher as Covid restrictions still worry
European shares crawled higher at the opening on Tuesday, with investor sentiment held back by worried over tighter coronavirus travel restrictions and rising UK unemployment.
CBI retail sales gauge slides to lowest level since May
UK retail sales fell to their lowest level in January since May 2020 as lockdown takes its toll, according to the latest survey from the Confederation of British Industry.
Operational strength to drive story at Indivior, Citi says
The removal of the Reckitt Benckiser overhang should allow operational strength to drive the story at opioid addiction treatment maker Indivior, Citi said on Tuesday.
TP Group margins impacted by Covid-19 pandemic
Mission-critical solutions provider TP Group said on Tuesday that the Covid-19 pandemic had impacted margins within certain programmes across the group during 2020.
Zoo Digital benefits from cloud-based offering amid Covid-19 pandemic
Localisation services provider Zoo Digital said on Tuesday that it had continued to see the benefits of its cloud-based offering and ability to undertake projects remotely amid the ongoing Covid-19 pandemic.
Asia report: Markets finish weaker, China web plays plunge
Markets in Asia were weaker across the board on Tuesday, with bourses in China leading the charge downwards, as investors monitored the latest developments on the Covid-19 front.
Saga expects FY pre-tax profits despite Covid-19 impacts
Over 50's specialist Saga said on Tuesday that it expects to report a full-year underlying pre-tax profit despite Covid-19 related challenges.
Ideagen finishes first half in line with forecasts
Regulatory and compliance software company Ideagen reported a first-half performance in line with market expectations on Tuesday, as its revenue increased 7% to £29. 2m.